Amneal Pharmaceuticals (AMRX) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free AMRX Stock Alerts $5.87 -0.03 (-0.51%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmneal Pharmaceuticals (NASDAQ:AMRX) Shares Gap Up to $5.40americanbankingnews.com - April 26 at 5:34 AMAmneal Pharmaceuticals (AMRX) Set to Announce Quarterly Earnings on Fridayamericanbankingnews.com - April 26 at 1:12 AMAmneal Pharmaceuticals (NASDAQ:AMRX) Trading Down 7.1%marketbeat.com - April 25 at 8:44 PMAllspring Global Investments Holdings LLC Sells 146,925 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - April 25 at 4:33 AMAmneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spraymarketwatch.com - April 24 at 3:01 PMAmneal's OTC Naloxone Nasal Spray Receives FDA Approval For Opioid Overdose Emergency Treatmentmarkets.businessinsider.com - April 24 at 9:17 AMAmneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdosebusinesswire.com - April 24 at 8:00 AMAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicinebusinesswire.com - April 16 at 8:00 AMAmneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past weekfinance.yahoo.com - April 15 at 8:42 AMPhocas Financial Corp. Buys Shares of 714,890 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - April 14 at 12:59 PMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 15.9% in Marchmarketbeat.com - April 14 at 7:50 AMAlkermes' Innovations Are Transforming Mental Health Treatmentsfinance.yahoo.com - April 11 at 3:01 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%marketbeat.com - April 10 at 2:51 PMAmneal to Report First Quarter 2024 Results on May 3, 2024businesswire.com - April 10 at 8:00 AM3 Lucrative Pharma Stocks to Diversify Your Investmentsstocknews.com - April 9 at 6:02 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 2.2%marketbeat.com - April 9 at 11:46 AMBausch Health drops after suing Amneal Pharma over Xifaxan genericmsn.com - April 8 at 4:09 PMVanguard Group Inc. Boosts Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - April 8 at 4:09 AMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Stock Position Decreased by Assenagon Asset Management S.A.marketbeat.com - April 7 at 4:36 AMBausch Health Sues Amneal Over IBS Treatment Patentmarketwatch.com - April 5 at 8:38 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volumemarketbeat.com - April 3 at 1:56 PMAmneal to Ring the Nasdaq Closing Bell on April 2, 2024businesswire.com - March 28 at 4:05 PMAmneal gains FDA greenlight to develop Ciprodex generic for ear infectionsmsn.com - March 27 at 2:52 AMAmneal Pharma Receives FDA Approval For Ciprofloxacin And Dexamethasone Otic Suspensionmarkets.businessinsider.com - March 25 at 10:31 PMAmneal Pharma Gets FDA Nod for Infection Fighting Drug Combinationmarketwatch.com - March 25 at 4:35 PMAmneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspensionfinance.yahoo.com - March 25 at 4:35 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Shares Gap Up After Analyst Upgrademarketbeat.com - March 21 at 3:14 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Price Target Raised to $8.00marketbeat.com - March 21 at 2:53 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 3.2%marketbeat.com - March 20 at 1:51 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Hits New 1-Year High at $6.38marketbeat.com - March 19 at 4:50 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 5.5%marketbeat.com - March 18 at 4:05 PMTop 3 Pharma Innovators to Watch Closelystocknews.com - March 18 at 2:05 PMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Sees Significant Decline in Short Interestmarketbeat.com - March 16 at 6:48 AMAmneal Pharmaceuticals (NASDAQ:AMRX) Presents a Compelling Option for Value Investorsmsn.com - March 8 at 7:42 PMAmneal Pharmaceuticals (NASDAQ:AMRX) PT Raised to $6.25marketbeat.com - March 4 at 10:26 AMAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 4 at 9:33 AMAmneal Pharmaceuticals (AMRX) Gets a Buy from Barclaysmarkets.businessinsider.com - March 4 at 9:12 AMAmneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 3 at 1:47 PMStrong Growth Ahead: Buy Rating for Amneal Pharmaceuticals Amidst Promising Product Launches and Financial Performancemarkets.businessinsider.com - March 1 at 10:40 PMWhy Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday?msn.com - March 1 at 12:39 PMAmneal Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 1 at 9:46 AMCaxton Associates LP Invests $508,000 in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - March 1 at 8:32 AMAmneal Pharmaceuticals Stock Rises 13% After 4Q Resultsmarketwatch.com - March 1 at 8:17 AMAmneal Pharmaceuticals (NASDAQ:AMRX) Issues FY 2024 Earnings Guidancemarketbeat.com - March 1 at 7:40 AMAmneal Pharmaceuticals: Q4 Earnings Insightsbenzinga.com - March 1 at 7:38 AMAmneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05, revenue of $617M misses by $17.86Mmsn.com - March 1 at 7:38 AMAmneal Pharmaceuticals Up 20% In Pre-market - Updatemarkets.businessinsider.com - March 1 at 7:38 AMAmneal Pharmaceuticals Inc (AMRX) Reports Mixed 2023 Financial Resultsfinance.yahoo.com - March 1 at 7:38 AMAmneal Reports Fourth Quarter and Full Year 2023 Financial Resultsbusinesswire.com - March 1 at 6:00 AMHere's what to expect from Amneal Pharmaceuticals A's earnings reportmarkets.businessinsider.com - February 29 at 11:36 AM Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 AMRX Media Mentions By Week AMRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼0.470.32▲Average Medical News Sentiment AMRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼83▲AMRX Articles Average Week Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HRMY News Today SUPN News Today GPCR News Today AGIO News Today TARO News Today AVDL News Today PTGX News Today DVAX News Today SDGR News Today SNDX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
